Table 3.
Variables | Findings |
---|---|
cblC defect | |
Biochemical | 94 % (n = 34/36) |
Genetic | 50 % (n = 18/36) |
Mutations (allelic frequency) | |
c.271dupA | 36 % (n = 13/36) |
c.276G>T | 17 % (n = 6/36) |
c.565C>A | 11 % (n = 4/36) |
Complement system | |
Normal | 87 % (n = 13/15) |
CFH-autoantibodies | 6.6 % (n = 1/15) |
CFH mutation | 6.6 % (n = 1/15) |